#45: Stock News Bot: AVII Stock News, AVI BioPharma Appoints Drs. Christopher S. Henney and M. Kathleen Behrens to Its Board of Directors
PORTLAND, OR -- (Marketwire) -- 03/31/09 -- AVI BioPharma, Inc. (NASDAQ: AVII... |
April 25, 2009
07:18:37 PM |
#44: Stock News Bot: AVII News AVI BioPharma Chairman and CEO Resigns
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII) today announced... |
March 28, 2007
06:00:00 AM |
#43: Stock News Bot: AVII News AVI BioPharma Announces 2006 Fourth Quarter and Full Year Financial Results
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (NASDAQ:AVII) today reported... |
March 15, 2007
01:00:00 AM |
#42: Stock News Bot: AVII News AVI BioPharma to Present Business Strategy at Cowen and Company's 27th Annual Health Care Conference
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), announced that... |
March 13, 2007
06:00:00 AM |
#41: Stock News Bot: AVII News AVI BioPharma Announces 2006 Fourth Quarter and Year End Financial Results Conference Call
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma Inc. (Nasdaq: AVII) today announced... |
March 8, 2007
01:00:00 AM |
#40: Stock News Bot: AVII News AVI BioPharma Presents Novel HIV Drug Candidate Results
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), presented... |
March 1, 2007
06:00:00 AM |
#39: Stock News Bot: AVII News AVI BioPharma and Eleos Announce Cross-License Agreement for p53 Therapeutics
PORTLAND, Ore. & OMAHA, Neb.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII),... |
January 9, 2007
06:00:00 AM |
#38: Stock News Bot: AVII News AVI BioPharma and Ercole Biotech Announce Cross-License and Drug Discovery Collaboration for Alternative Splicing Therapeutics
PORTLAND, Ore. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--AVI BioPharma,... |
December 20, 2006
06:00:00 AM |
#37: Stock News Bot: AVII News AVI BioPharma Announces Clinical Development Initiative for Muscular Dystrophy
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq: AVII) today... |
December 7, 2006
06:00:00 AM |
#36: Stock News Bot: AVII News AVI BioPharma Awarded $28 Million Biodefense Research Contract by Department of Defense/DTRA
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq: AVII), has executed... |
December 4, 2006
06:00:00 AM |
#35: Stock News Bot: AVII News AVI BioPharma Announces Positive Clinical Trial Results Delivering NEUGENE Antisense Drugs to the Central Nervous System
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), today... |
November 10, 2006
06:00:00 AM |
#34: Stock News Bot: AVII News AVI BioPharma Reports Third Quarter Financial Results
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII) today reported... |
November 8, 2006
01:00:00 AM |
#33: Stock News Bot: AVII News AVI BioPharma to Present Strategic Overview at Two Investor Conferences
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), President and... |
November 6, 2006
06:00:00 AM |
#32: Stock News Bot: AVII News AVI BioPharma Announces 2006 Third Quarter Financial Results Conference Call
PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma Inc. (Nasdaq: AVII) today announced... |
November 1, 2006
01:00:00 AM |
#31: Stock News Bot: AVII News AVI BioPharma Discusses Phase II Cardiovascular Clinical Study
PORTLAND, Ore.--(BUSINESS WIRE)--Clinicians involved in the performance of the... |
October 31, 2006
06:00:00 AM |
